Related Articles
O6‑methylguanine‑DNA methyltransferase as a prognostic and predictive marker for basal‑like breast cancer treated with cyclophosphamide‑based chemotherapy
Predictive value of the MGMT promoter methylation status in metastatic melanoma patients receiving first-line temozolomide plus bevacizumab in the trial SAKK 50/07
Selection of chemotherapy for glioblastoma expressing O6-methylguanine-DNA methyltransferase
The promoter methylation and expression of the O6-methylguanine-DNA methyltransferase gene in uterine sarcoma and carcinosarcoma
Relationship between MGMT gene expression and treatment effectiveness and prognosis in glioma